(3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione

C134H140N50O16 — CID 159250862

About (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione

(3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione (PubChem CID 159250862) has the molecular formula C134H140N50O16 and a molecular weight of 2706.93 g/mol. Its IUPAC name is (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione.

Molecular Properties

• Compound Name: (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione
• PubChem CID: 159250862
• Molecular Formula: C134H140N50O16
• Molecular Weight: 2706.93 g/mol
• Exact Mass: 2705.17
• IUPAC Name: (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione
• SMILES: CCN1CCN(C(=O)c2ccc3c(c2)ncn3-c2nc(NC3CC3)n3ncc(/C=C4\CC(=O)NC4=O)c3n2)CC1.CN(C)C1CCN(C(=O)c2ccc3c(c2)ncn3-c2nc(NC3CC3)n3ncc(/C=C4\CC(=O)NC4=O)c3n2)C1.CN(C)CCNC(=O)c1ccc2c(c1)ncn2-c1nc(NC2CC2)n2ncc(/C=C3\CC(=O)NC3=O)c2n1.O=C1C/C(=C\c2cnn3c(NC4CC4)nc(-n4cnc5cc(C(=O)NCCCN6CCCC6)ccc54)nc23)C(=O)N1.O=C1C/C(=C\c2cnn3c(NC4CC4)nc(-n4cnc5cc(C(=O)NCCN6CCOCC6)ccc54)nc23)C(=O)N1
• InChI: InChI=1S/C28H30N10O3.C27H28N10O4.2C27H28N10O3.C25H26N10O3/c39-23-14-18(26(41)33-23)12-19-15-31-38-24(19)34-27(35-28(38)32-20-5-6-20)37-16-30-21-13-17(4-7-22(21)37)25(40)29-8-3-11-36-9-1-2-10-36;38-22-13-17(25(40)32-22)11-18-14-30-37-23(18)33-26(34-27(37)31-19-2-3-19)36-15-29-20-12-16(1-4-21(20)36)24(39)28-5-6-35-7-9-41-10-8-35;1-34(2)19-7-8-35(13-19)25(40)15-3-6-21-20(10-15)28-14-36(21)26-32-23-17(9-16-11-22(38)31-24(16)39)12-29-37(23)27(33-26)30-18-4-5-18;1-2-34-7-9-35(10-8-34)25(40)16-3-6-21-20(12-16)28-15-36(21)26-32-23-18(11-17-13-22(38)31-24(17)39)14-29-37(23)27(33-26)30-19-4-5-19;1-33(2)8-7-26-22(37)14-3-6-19-18(10-14)27-13-34(19)24-31-21-16(9-15-11-20(36)30-23(15)38)12-28-35(21)25(32-24)29-17-4-5-17/h4,7,12-13,15-16,20H,1-3,5-6,8-11,14H2,(H,29,40)(H,32,34,35)(H,33,39,41);1,4,11-12,14-15,19H,2-3,5-10,13H2,(H,28,39)(H,31,33,34)(H,32,38,40);3,6,9-10,12,14,18-19H,4-5,7-8,11,13H2,1-2H3,(H,30,32,33)(H,31,38,39);3,6,11-12,14-15,19H,2,4-5,7-10,13H2,1H3,(H,30,32,33)(H,31,38,39);3,6,9-10,12-13,17H,4-5,7-8,11H2,1-2H3,(H,26,37)(H,29,31,32)(H,30,36,38)/b18-12+;17-11+;16-9+;17-11+;15-9+
• InChIKey: KVGXOQGUKQQADC-BOCAGSKDSA-N
• XLogP: 5.46
• TPSA: 748.85 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 56
• Rotatable Bonds: 37
• Heavy Atoms: 200
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2706.93
LogP ≤ 5	5.46
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	56

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione?

The IUPAC name of (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione (CID 159250862) is (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione.

What is the SMILES notation for (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione?

The canonical SMILES for (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione is CCN1CCN(C(=O)c2ccc3c(c2)ncn3-c2nc(NC3CC3)n3ncc(/C=C4\CC(=O)NC4=O)c3n2)CC1.CN(C)C1CCN(C(=O)c2ccc3c(c2)ncn3-c2nc(NC3CC3)n3ncc(/C=C4\CC(=O)NC4=O)c3n2)C1.CN(C)CCNC(=O)c1ccc2c(c1)ncn2-c1nc(NC2CC2)n2ncc(/C=C3\CC(=O)NC3=O)c2n1.O=C1C/C(=C\c2cnn3c(NC4CC4)nc(-n4cnc5cc(C(=O)NCCCN6CCCC6)ccc54)nc23)C(=O)N1.O=C1C/C(=C\c2cnn3c(NC4CC4)nc(-n4cnc5cc(C(=O)NCCN6CCOCC6)ccc54)nc23)C(=O)N1.

What is the InChIKey of (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione?

The InChIKey is KVGXOQGUKQQADC-BOCAGSKDSA-N. The full InChI is InChI=1S/C28H30N10O3.C27H28N10O4.2C27H28N10O3.C25H26N10O3/c39-23-14-18(26(41)33-23)12-19-15-31-38-24(19)34-27(35-28(38)32-20-5-6-20)37-16-30-21-13-17(4-7-22(21)37)25(40)29-8-3-11-36-9-1-2-10-36;38-22-13-17(25(40)32-22)11-18-14-30-37-23(18)33-26(34-27(37)31-19-2-3-19)36-15-29-20-12-16(1-4-21(20)36)24(39)28-5-6-35-7-9-41-10-8-35;1-34(2)19-7-8-35(13-19)25(40)15-3-6-21-20(10-15)28-14-36(21)26-32-23-17(9-16-11-22(38)31-24(16)39)12-29-37(23)27(33-26)30-18-4-5-18;1-2-34-7-9-35(10-8-34)25(40)16-3-6-21-20(12-16)28-15-36(21)26-32-23-18(11-17-13-22(38)31-24(17)39)14-29-37(23)27(33-26)30-19-4-5-19;1-33(2)8-7-26-22(37)14-3-6-19-18(10-14)27-13-34(19)24-31-21-16(9-15-11-20(36)30-23(15)38)12-28-35(21)25(32-24)29-17-4-5-17/h4,7,12-13,15-16,20H,1-3,5-6,8-11,14H2,(H,29,40)(H,32,34,35)(H,33,39,41);1,4,11-12,14-15,19H,2-3,5-10,13H2,(H,28,39)(H,31,33,34)(H,32,38,40);3,6,9-10,12,14,18-19H,4-5,7-8,11,13H2,1-2H3,(H,30,32,33)(H,31,38,39);3,6,11-12,14-15,19H,2,4-5,7-10,13H2,1H3,(H,30,32,33)(H,31,38,39);3,6,9-10,12-13,17H,4-5,7-8,11H2,1-2H3,(H,26,37)(H,29,31,32)(H,30,36,38)/b18-12+;17-11+;16-9+;17-11+;15-9+.

What are the key properties of (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione?

(3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione has a molecular weight of 2706.93 g/mol, XLogP of 5.46, 37 rotatable bonds, 13 hydrogen bond donors, and 56 hydrogen bond acceptors.

Where does this data come from?

All data for (3E)-3-[[4-(cyclopropylamino)-2-[5-[3-(dimethylamino)pyrrolidine-1-carbonyl]benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-[2-(dimethylamino)ethyl]benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(2-morpholin-4-ylethyl)benzimidazole-5-carboxamide;1-[4-(cyclopropylamino)-8-[(E)-(2,5-dioxopyrrolidin-3-ylidene)methyl]pyrazolo[1,5-a][1,3,5]triazin-2-yl]-N-(3-pyrrolidin-1-ylpropyl)benzimidazole-5-carboxamide;(3E)-3-[[4-(cyclopropylamino)-2-[5-(4-ethylpiperazine-1-carbonyl)benzimidazol-1-yl]pyrazolo[1,5-a][1,3,5]triazin-8-yl]methylidene]pyrrolidine-2,5-dione is sourced from PubChem (CID 159250862), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).